Evercore ISI Raises GE HealthCare Technologies (NASDAQ:GEHC) Price Target to $102.00

GE HealthCare Technologies (NASDAQ:GEHC) had its target price upped by Evercore ISI from $98.00 to $102.00 in a research report report published on Tuesday morning, Benzinga reports. They currently have an outperform rating on the stock.

Other research analysts have also issued research reports about the company. UBS Group lowered GE HealthCare Technologies from a neutral rating to a sell rating and lowered their price target for the stock from $84.00 to $74.00 in a research report on Thursday, September 26th. JPMorgan Chase & Co. started coverage on GE HealthCare Technologies in a research report on Monday, September 9th. They set a neutral rating and a $90.00 price target on the stock. Stifel Nicolaus boosted their price target on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a buy rating in a research report on Monday. BTIG Research raised GE HealthCare Technologies from a neutral rating to a buy rating and set a $100.00 target price on the stock in a report on Wednesday, September 18th. Finally, Redburn Atlantic raised GE HealthCare Technologies to a strong-buy rating in a report on Thursday, August 1st. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, seven have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of Moderate Buy and an average target price of $94.23.

GE HealthCare Technologies Trading Down 1.3 %

NASDAQ GEHC opened at $89.88 on Tuesday. The stock has a market capitalization of $41.03 billion, a price-to-earnings ratio of 26.28, a PEG ratio of 3.40 and a beta of 1.17. The stock’s 50 day moving average price is $85.83 and its two-hundred day moving average price is $83.33. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.82 and a current ratio of 1.06. GE HealthCare Technologies has a 52 week low of $62.35 and a 52 week high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, beating the consensus estimate of $0.98 by $0.02. The firm had revenue of $4.84 billion for the quarter, compared to analysts’ expectations of $4.88 billion. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The business’s quarterly revenue was up .5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.92 EPS. As a group, analysts anticipate that GE HealthCare Technologies will post 4.26 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a yield of 0.13%. The ex-dividend date is Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio is 3.51%.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the company’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total value of $222,145.00. Following the transaction, the chief executive officer now directly owns 17,509 shares of the company’s stock, valued at approximately $1,414,377.02. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.27% of the company’s stock.

Institutional Trading of GE HealthCare Technologies

Institutional investors have recently modified their holdings of the stock. Global Assets Advisory LLC bought a new stake in shares of GE HealthCare Technologies during the 1st quarter valued at $4,273,000. Vanguard Group Inc. lifted its position in shares of GE HealthCare Technologies by 9.2% during the 1st quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock valued at $4,410,893,000 after acquiring an additional 4,107,746 shares during the period. Mather Group LLC. bought a new stake in shares of GE HealthCare Technologies during the 1st quarter valued at $106,000. Bank of Montreal Can lifted its position in shares of GE HealthCare Technologies by 27.5% during the 2nd quarter. Bank of Montreal Can now owns 696,446 shares of the company’s stock valued at $54,964,000 after acquiring an additional 150,137 shares during the period. Finally, Sei Investments Co. lifted its position in shares of GE HealthCare Technologies by 30.6% during the 1st quarter. Sei Investments Co. now owns 279,336 shares of the company’s stock worth $25,393,000 after buying an additional 65,476 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.